Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 18 of 18 entries
Sorted by: Best Match Show Resources per page
Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study.

Breast cancer (Tokyo, Japan)

Pappot H, Baeksted CW, Nissen A, Knoop A, Mitchell SA, Christensen J, Hjollund NH, Johansen C.
PMID: 33837509
Breast Cancer. 2021 Sep;28(5):1096-1099. doi: 10.1007/s12282-021-01244-x. Epub 2021 Apr 09.

The involvement of cancer patients in symptom reporting talks into our cultural narrative of empowerment and participation in decisions in health of both patients and professionals. Electronic patient-reported outcome (ePRO) is a tool applied for use in such interaction....

Cite
Pappot H, Baeksted CW, Nissen A, et al. Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study. Breast Cancer. 2021;28(5):1096-1099doi: 10.1007/s12282-021-01244-x.
Pappot, H., Baeksted, C. W., Nissen, A., Knoop, A., Mitchell, S. A., Christensen, J., Hjollund, N. H., & Johansen, C. (2021). Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study. Breast cancer (Tokyo, Japan), 28(5), 1096-1099. https://doi.org/10.1007/s12282-021-01244-x
Pappot, Helle, et al. "Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study." Breast cancer (Tokyo, Japan) vol. 28,5 (2021): 1096-1099. doi: https://doi.org/10.1007/s12282-021-01244-x
Pappot H, Baeksted CW, Nissen A, Knoop A, Mitchell SA, Christensen J, Hjollund NH, Johansen C. Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study. Breast Cancer. 2021 Sep;28(5):1096-1099. doi: 10.1007/s12282-021-01244-x. Epub 2021 Apr 09. PMID: 33837509.
Copy Download .nbib Format: NLM
Randomized controlled study to evaluate the impact of flexible patient-controlled visits in people with type 1 diabetes: The DiabetesFlex Trial.

Diabetic medicine : a journal of the British Diabetic Association

Laurberg T, Schougaard LMV, Hjollund NHI, Lomborg KE, Hansen TK, Jensen AL.
PMID: 35028992
Diabet Med. 2022 Jan 13;e14791. doi: 10.1111/dme.14791. Epub 2022 Jan 13.

AIM: The objective of this study was to assess the impact of health care-initiated visits versus patient-controlled flexible visits on clinical and patient-reported outcomes in people with type 1 diabetes.METHODS: The DiabetesFlex trial was a randomized controlled, pragmatic non-inferiority...

Cite
Laurberg T, Schougaard LMV, Hjollund NHI, et al. Randomized controlled study to evaluate the impact of flexible patient-controlled visits in people with type 1 diabetes: The DiabetesFlex Trial. Diabet Med. 2022;e14791doi: 10.1111/dme.14791.
Laurberg, T., Schougaard, L. M. V., Hjollund, N. H. I., Lomborg, K. E., Hansen, T. K., & Jensen, A. L. (2022). Randomized controlled study to evaluate the impact of flexible patient-controlled visits in people with type 1 diabetes: The DiabetesFlex Trial. Diabetic medicine : a journal of the British Diabetic Association, e14791. https://doi.org/10.1111/dme.14791
Laurberg, Tinne, et al. "Randomized controlled study to evaluate the impact of flexible patient-controlled visits in people with type 1 diabetes: The DiabetesFlex Trial." Diabetic medicine : a journal of the British Diabetic Association vol. (2022): e14791. doi: https://doi.org/10.1111/dme.14791
Laurberg T, Schougaard LMV, Hjollund NHI, Lomborg KE, Hansen TK, Jensen AL. Randomized controlled study to evaluate the impact of flexible patient-controlled visits in people with type 1 diabetes: The DiabetesFlex Trial. Diabet Med. 2022 Jan 13;e14791. doi: 10.1111/dme.14791. Epub 2022 Jan 13. PMID: 35028992.
Copy Download .nbib Format: NLM
Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer.

Clinical lung cancer

Friis RB, Hjøllund NH, Pappot H, Taarnhøj GA, Vestergaard JM, Skuladottir H.
PMID: 33160899
Clin Lung Cancer. 2021 Mar;22(2):e169-e179. doi: 10.1016/j.cllc.2020.09.014. Epub 2020 Oct 15.

BACKGROUND: Patient-reported outcome (PRO) measures have been increasingly implemented in routine care to aid in clinical decision-making. However, the prognostic value of PRO measures as a tool for decision making is not easily interpreted by clinicians. Our aims were...

Cite
Friis RB, Hjøllund NH, Pappot H, et al. Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer. Clin Lung Cancer. 2020;22(2):e169-e179doi: 10.1016/j.cllc.2020.09.014.
Friis, R. B., Hjøllund, N. H., Pappot, H., Taarnhøj, G. A., Vestergaard, J. M., & Skuladottir, H. (2021). Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer. Clinical lung cancer, 22(2), e169-e179. https://doi.org/10.1016/j.cllc.2020.09.014
Friis, Rasmus Blechingberg, et al. "Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer." Clinical lung cancer vol. 22,2 (2021): e169-e179. doi: https://doi.org/10.1016/j.cllc.2020.09.014
Friis RB, Hjøllund NH, Pappot H, Taarnhøj GA, Vestergaard JM, Skuladottir H. Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer. Clin Lung Cancer. 2021 Mar;22(2):e169-e179. doi: 10.1016/j.cllc.2020.09.014. Epub 2020 Oct 15. PMID: 33160899.
Copy Download .nbib Format: NLM
Association of patient-reported outcomes and ovarian cancer recurrence.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Kargo AS, Jensen PT, Lindemann K, Hjøllund NH, Liposits GI, Raaschou-Jensen N, Knudsen BM, Möller S, Hansen DG, Steffensen KD.
PMID: 34489355
Int J Gynecol Cancer. 2021 Sep;31(9):1248-1259. doi: 10.1136/ijgc-2021-002550. Epub 2021 Jun 18.

BACKGROUND: The vast majority of patients with advanced ovarian cancer experience disease recurrence after primary treatment.OBJECTIVE: To explore the diagnostic accuracy of repeated measurement of patient-reported outcomes and quality-of-life scores in relation to ovarian cancer recurrence.METHODS: Patients with ovarian...

Cite
Kargo AS, Jensen PT, Lindemann K, et al. Association of patient-reported outcomes and ovarian cancer recurrence. Int J Gynecol Cancer. 2021;31(9):1248-1259doi: 10.1136/ijgc-2021-002550.
Kargo, A. S., Jensen, P. T., Lindemann, K., Hjøllund, N. H., Liposits, G. I., Raaschou-Jensen, N., Knudsen, B. M., Möller, S., Hansen, D. G., & Steffensen, K. D. (2021). Association of patient-reported outcomes and ovarian cancer recurrence. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 31(9), 1248-1259. https://doi.org/10.1136/ijgc-2021-002550
Kargo, Anette Stolberg, et al. "Association of patient-reported outcomes and ovarian cancer recurrence." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 31,9 (2021): 1248-1259. doi: https://doi.org/10.1136/ijgc-2021-002550
Kargo AS, Jensen PT, Lindemann K, Hjøllund NH, Liposits GI, Raaschou-Jensen N, Knudsen BM, Möller S, Hansen DG, Steffensen KD. Association of patient-reported outcomes and ovarian cancer recurrence. Int J Gynecol Cancer. 2021 Sep;31(9):1248-1259. doi: 10.1136/ijgc-2021-002550. Epub 2021 Jun 18. PMID: 34489355.
Copy Download .nbib Format: NLM
Using multiple imputation to deal with missing data and attrition in longitudinal studies with repeated measures of patient-reported outcomes.

Clinical epidemiology

Biering K, Hjollund NH, Frydenberg M.
PMID: 25653557
Clin Epidemiol. 2015 Jan 16;7:91-106. doi: 10.2147/CLEP.S72247. eCollection 2015.

OBJECTIVE: Missing data is a ubiquitous problem in studies using patient-reported measures, decreasing sample sizes and causing possible bias. In longitudinal studies, special problems relate to attrition and death during follow-up. We describe a methodological approach for the use...

Cite
Biering K, Hjollund NH, Frydenberg M. Using multiple imputation to deal with missing data and attrition in longitudinal studies with repeated measures of patient-reported outcomes. Clin Epidemiol. 2015;7:91-106doi: 10.2147/CLEP.S72247.
Biering, K., Hjollund, N. H., & Frydenberg, M. (2015). Using multiple imputation to deal with missing data and attrition in longitudinal studies with repeated measures of patient-reported outcomes. Clinical epidemiology, 791-106. https://doi.org/10.2147/CLEP.S72247
Biering, Karin, et al. "Using multiple imputation to deal with missing data and attrition in longitudinal studies with repeated measures of patient-reported outcomes." Clinical epidemiology vol. 7 (2015): 91-106. doi: https://doi.org/10.2147/CLEP.S72247
Biering K, Hjollund NH, Frydenberg M. Using multiple imputation to deal with missing data and attrition in longitudinal studies with repeated measures of patient-reported outcomes. Clin Epidemiol. 2015 Jan 16;7:91-106. doi: 10.2147/CLEP.S72247. eCollection 2015. PMID: 25653557; PMCID: PMC4303367.
Copy Download .nbib Format: NLM
Self-reported health following percutaneous coronary intervention: results from a cohort followed for 3 years with multiple measurements.

Clinical epidemiology

Biering K, Frydenberg M, Hjollund NH.
PMID: 25506246
Clin Epidemiol. 2014 Dec 03;6:441-9. doi: 10.2147/CLEP.S65476. eCollection 2014.

OBJECTIVE: Improvements in the treatment of coronary heart disease have increased the number of patients living with a chronic heart disease. Patient-reported outcomes are required to adequately describe prognosis. We report self-rated health in a population-based cohort of patients...

Cite
Biering K, Frydenberg M, Hjollund NH. Self-reported health following percutaneous coronary intervention: results from a cohort followed for 3 years with multiple measurements. Clin Epidemiol. 2014;6:441-9doi: 10.2147/CLEP.S65476.
Biering, K., Frydenberg, M., & Hjollund, N. H. (2014). Self-reported health following percutaneous coronary intervention: results from a cohort followed for 3 years with multiple measurements. Clinical epidemiology, 6441-9. https://doi.org/10.2147/CLEP.S65476
Biering, Karin, et al. "Self-reported health following percutaneous coronary intervention: results from a cohort followed for 3 years with multiple measurements." Clinical epidemiology vol. 6 (2014): 441-9. doi: https://doi.org/10.2147/CLEP.S65476
Biering K, Frydenberg M, Hjollund NH. Self-reported health following percutaneous coronary intervention: results from a cohort followed for 3 years with multiple measurements. Clin Epidemiol. 2014 Dec 03;6:441-9. doi: 10.2147/CLEP.S65476. eCollection 2014. PMID: 25506246; PMCID: PMC4259550.
Copy Download .nbib Format: NLM
Showing 13 to 18 of 18 entries